Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel/Ethinyl Estradiol for Oral Contraception
NCT00245921Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2003
- Primary completion
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of avatrombopag and ethinyl estradiol in pregnancy, sponsored by Pfizer. Primary endpoints: Contraceptive Efficacy at 1 year and Safety. Started Feb 2003; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00245921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245921.